Organization
Beckley Psytech
6 clinical trials
Clinical trial
An Open-Label, Phase 2a Single Dose Study in Patients With Alcohol Use DisorderStatus: Recruiting, Estimated PCD: 2024-10-01
Clinical trial
An Open-Label, Phase 2a, Single Dose Study to Evaluate the Safety, Tolerability and Pharmacodynamics of BPL-003 in Patients With Treatment Resistant DepressionStatus: Recruiting, Estimated PCD: 2024-11-01
Clinical trial
A Two-part Phase 1, Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of Intranasal BPL-003 (5-Methoxy-N,N-dimethyltryptamine Benzoate) in Healthy SubjectsStatus: Completed, Estimated PCD: 2024-01-19
Clinical trial
An Exploratory Open-Label, Phase 1b, Ascending Dose Study to Evaluate the Effects of Oral 3-[2-(Dimethylamino)Ethyl]-1h-indol-4-yl Dihydrogen Phosphate (Psilocybin, BPL-PSILO) on Cognition in Patients With Chronic Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA)Status: Terminated, Estimated PCD: 2022-04-22
Clinical trial
A Double-Blind, Randomized, Phase 1, First-in-Human, Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of Intranasal 5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in Healthy SubjectsStatus: Completed, Estimated PCD: 2022-07-07
Clinical trial
A Quadruple Masked, Dose-Finding Study to Evaluate the Efficacy and Safety of Intranasal BPL-003 in Patients With Treatment Resistant DepressionStatus: Recruiting, Estimated PCD: 2024-10-01